The Biological and Chemical Technologies Group addresses significant current and emerging national security challenges using advanced biological and chemical technologies. Capabilities within the Group include molecular, cellular, and synthetic biology; microbiome engineering; rapid DNA sequencing; bioinformatics; microfluidics; mass spectrometry; laser spectroscopy; and organic chemistry. These capabilities are applied to missions spanning chemical, biological, and explosives (CBE) detection and attribution; medical diagnostics and countermeasures; pathogen identification; point-of-care diagnostics; molecular intelligence; biosecurity; biomanufacturing, DNA forensics, and additive manufacturing.